Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial of GTI-2040 in combination with capecitabine in metastatic breast cancer completed; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy [NA]
A completed clinical trial evaluating the impact of nutritional intervention in women with breast cancer undergoing adjuvant chemotherapy.
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating doxorubicin hydrochloride liposome as first-line therapy in older women with metastatic breast cancer has complet…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer [Phase 3]
Phase 3 trial of trastuzumab (Herceptin) in combination chemotherapy for locally advanced breast cancer has completed, with results posted i…
-
FDA approval · 2014-10-25FDA Approved: CYCLOPHOSPHAMIDE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Civica, Inc. to market a generic cyclophosphamide product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. [Phase 3]
THOR Phase 3 trial evaluating continued trastuzumab (Herceptin) with second-line chemotherapy in HER2-positive metastatic breast cancer; res…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer [Phase 1]
A Phase 1 trial evaluated MK-2206 in combination with lapatinib in patients with advanced or metastatic breast cancer, including HER2-positi…
-
CLINICAL_TRIALS withdrawal · 2014-10-23Clinical Trial Update: 18-F-Fluoroacetate as PET Imaging Agent [Phase 1]
A Phase 1 trial of the PET imaging agent 18-F-Fluoroacetate sponsored by MD Anderson Cancer Center was withdrawn, with conditions including …
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy [Phase 2]
Phase 2 trial completed evaluating prevention of cardiac dysfunction during adjuvant therapy for breast cancer.
-
CLINICAL_TRIALS research · 2014-10-21Clinical Trial Update: Redes II National Patient Navigator Intervention Study [NA]
This is a completed update on the Redes II National Patient Navigator Intervention Study, sponsored by The University of Texas Health Scienc…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction [Phase 2]
A Phase 2 trial evaluating drain antisepsis after tissue expander breast reconstruction has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer [Phase 1]
A Phase 1 clinical trial evaluated letrozole for the prevention of breast cancer in healthy postmenopausal women at high risk; the study sta…
-
CLINICAL_TRIALS research · 2014-10-20Clinical Trial Update: Ultrasound-based Breast Cancer Screening in Chinese Women
An update on a clinical trial evaluating ultrasound-based breast cancer screening in Chinese women. The current status is unknown and result…
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Phase I: At-Home Support for Rural Women Using Group Video Calling [Phase 1]
Phase I trial completion of an at-home group video calling support program for rural women, focusing on depression and post-traumatic stress…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Effect of Concomitant Radiotherapy and Trastuzumab on Cardiotoxicity of Patients Treated for Early Breast Cancer
The trial update reports on cardiotoxicity outcomes when radiotherapy is given concurrently with trastuzumab in patients with early breast c…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue. [Phase 1, Phase 2]
This clinical trial update reports on the distribution of indocyanine green (ICG) in benign and malignant breast tissue using near-infrared …
-
CLINICAL_TRIALS research · 2014-10-15Clinical Trial Update: Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer [Phase 2]
Phase 2 preoperative study evaluating weekly paclitaxel and carboplatin with lapatinib (Tykerb) in ErbB2/HER2-positive Stage I–III breast ca…
-
CLINICAL_TRIALS withdrawal · 2014-10-15Clinical Trial Update: Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Cancer [NA]
A clinical trial evaluating Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy for breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: BIG Molecular Screening Feasibility Study [NA]
The BIG Molecular Screening Feasibility Study, sponsored by Jules Bordet Institute, for metastatic breast cancer has completed.
-
FDA approval · 2014-10-14FDA Approved: KIT FOR THE PREPARATION OF LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) — Supplemental Application (Cardinal Health 414, LLC)
The FDA approved a supplemental application to authorize Cardinal Health 414, LLC to prepare the Lymphoseek radiopharmaceutical kit (technet…
-
FDA approval · 2014-10-10FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Faslodex Post Marketing Surveillance
A post-marketing surveillance trial evaluating Faslodex (fulvestrant) in breast cancer has completed.
-
CLINICAL_TRIALS research · 2014-10-10Clinical Trial Update: ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer [Phase 2]
Bayer reports completion of a Phase 2 clinical trial evaluating ZK 230211 in postmenopausal women with metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older [Phase 3]
Phase 3 trial comparing doxorubicin versus capecitabine for metastatic breast cancer in women 60 years and older has been terminated.
-
CLINICAL_TRIALS withdrawal · 2014-10-08Clinical Trial Update: Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer [Phase 2]
A Phase 2 trial of fulvestrant with and without entinostat in postmenopausal women with ER-positive advanced breast cancer has been withdraw…